spacer
home > pmps > winter 2018 > patience with patients
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Patience with Patients

What is patient adherence?

As defined by the WHO, patient adherence is the extent to which a person’s behaviour – for example, taking medication, following a diet or executing lifestyle changes – corresponds with the agreed recommendations from a healthcare provider. A low level of adherence means that the likelihood of patients taking their prescribed medication correctly is small, which can be very dangerous, in some cases.

Would you say that this is a growing or lessening concern for the pharmaceutical industry and why?

Patient adherence is currently one of the biggest challenges that the pharma industry is facing and remains a growing concern. Not only do low patient adherence levels affect healthcare efficacy, it is also extremely costly to the industry. Research shows that patients not taking their medication in line with recommendations costs the NHS £500 million per year, which, in context, is equivalent to 30,000 kidney transplants or an extra 21,000 qualified nurses.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rupert Taylor joined Essentra in 2014 as Global Category Manager Household for food and drink. He is now Global Category Manager for healthcare and personal care. Rupert’s role is to identify customer and consumer needs in the market place and deliver those solutions through the company’s portfolio of packaging, components, special technologies, security, and authentication. Prior to joining Essentra, he worked as Marketing and Innovation Director for Puratos, Brazil. Rupert’s experience spans over 20 years in delivering results in both B2B and B2C environments on a global basis.
spacer
Rupert Taylor
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Teknomek’s latest seating bench steps up, and over

Teknomek’s long-serving free-standing stainless steel seating bench has been updated with a raft of design tweaks to make it even more hygienic, easy clean and ergonomic.
More info >>

White Papers

Transforming Temperature Data Management Practices to Reduce Labor Costs and Improve Visibility and Control

Berlinger & Co AG

There are a number of temperature monitoring database options available to the biopharma supply chain professional and choosing the right one can significantly improve workflow which will reduce administrative time. This article will provide insight into practices for improving common processes through enhanced database functionality in the areas of managing data loggers by expiry date, storing and retrieving calibration certificates and acknowledging/documenting common temperature excursion events. Additionally, it describes the unique features and benefits of the Berlinger Smartview® data management system. Smartview® is a “Software as a Service” (SaaS) platform designed to efficiently and accurately manage both workflow and data in a regulatory compliant manner (21 CRF Part 11 & Annex 11). This comprehensive temperature data management system ensures reliability, accuracy, security, accessibility, and visibility to supply chain professionals, enhancing Good Distribution Practices (GDP) of temperature sensitive shipments.
More info >>

 
Industry Events

PREP 2018: 31st International Symposium and Exhibit on Preparative and Process Chromatography

8-11 July 2018, Hyatt Regency in the Baltimore Inner Harbor, MD, USA

The PREP series of symposia is the most recognized international conference devoted to advances in separation technologies in the field of preparative and process chromatography. Join us for a dynamic and innovative program where experts from around the world will address the latest developments and hottest topics in preparative and process chromatography.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement